185 related articles for article (PubMed ID: 15864228)
21. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
[TBL] [Abstract][Full Text] [Related]
22. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials.
De Luca G; Suryapranata H; Stone GW; Antoniucci D; Neumann FJ; Chiariello M
Am Heart J; 2007 Mar; 153(3):343-53. PubMed ID: 17307410
[TBL] [Abstract][Full Text] [Related]
23. Acute myocardial infarction.
Danchin N; Urban P; De Benedetti E
Clin Evid; 2002 Jun; (7):11-35. PubMed ID: 12230636
[No Abstract] [Full Text] [Related]
24. Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction.
Armstrong PW; Mahaffey KW; Chang WC; Weaver WD; Hochman JS; Theroux P; Rollins S; Todaro TG; Granger CB;
Am Heart J; 2006 Apr; 151(4):787-90. PubMed ID: 16569534
[TBL] [Abstract][Full Text] [Related]
25. Can beta-blocker use lower mortality and improve myocardial tissue recovery after acute myocardial infarction?
Faxon DP
Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):14-5. PubMed ID: 16265251
[No Abstract] [Full Text] [Related]
26. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
27. Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview.
Mahaffey KW; Van de Werf F; Shernan SK; Granger CB; Verrier ED; Filloon TG; Todaro TG; Adams PX; Levy JH; Hasselblad V; Armstrong PW
Am Heart J; 2006 Aug; 152(2):291-6. PubMed ID: 16875911
[TBL] [Abstract][Full Text] [Related]
28. Rheolytic thrombectomy in acute myocardial infarction: the Florence experience and objectives of the multicenter randomized JETSTENT trial.
Antoniucci D
J Invasive Cardiol; 2006 Jul; 18 Suppl C():32C-34C. PubMed ID: 16883031
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction.
Martinez-Ojeda J; Martinez-Toro J
Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071
[TBL] [Abstract][Full Text] [Related]
30. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.
Brodie BR; Stuckey TD; Hansen C; Bradshaw BH; Downey WE; Pulsipher MW
Am J Cardiol; 2007 Feb; 99(4):431-5. PubMed ID: 17293178
[TBL] [Abstract][Full Text] [Related]
31. Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction.
Palmeri ST; Lowe AM; Sleeper LA; Saucedo JF; Desvigne-Nickens P; Hochman JS;
Am J Cardiol; 2005 Oct; 96(8):1042-9. PubMed ID: 16214435
[TBL] [Abstract][Full Text] [Related]
32. Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI.
Tjandrawidjaja MC; Fu Y; Al-Khalidi H; Todaro TG; Adams P; Van de Werf F; Granger CB; Armstrong PW;
Eur Heart J; 2007 Dec; 28(23):2850-7. PubMed ID: 17967823
[TBL] [Abstract][Full Text] [Related]
33. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
[TBL] [Abstract][Full Text] [Related]
34. Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients.
Haverich A; Shernan SK; Levy JH; Chen JC; Carrier M; Taylor KM; Van de Werf F; Newman MF; Adams PX; Todaro TG; van der Laan M; Verrier ED
Ann Thorac Surg; 2006 Aug; 82(2):486-92. PubMed ID: 16863750
[TBL] [Abstract][Full Text] [Related]
35. Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library.
Mahaffey KW; Reist CJ; Fu Y; Brener SJ; Theroux P; Patel MR; Stebbins A; Westerhout CM; Todaro TG; Adams PX; Granger CB; Armstrong PW;
Contemp Clin Trials; 2008 Nov; 29(6):887-95. PubMed ID: 18644468
[TBL] [Abstract][Full Text] [Related]
36. Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
Ishii H; Ichimiya S; Kanashiro M; Amano T; Ogawa Y; Mitsuhashi H; Sakai S; Uetani T; Murakami R; Naruse K; Murohara T; Matsubara T
Am J Cardiol; 2007 May; 99(9):1203-7. PubMed ID: 17478142
[TBL] [Abstract][Full Text] [Related]
37. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.
Chiu FC; Chang SN; Lin JW; Hwang JJ; Chen YS
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1326-30. PubMed ID: 19660378
[TBL] [Abstract][Full Text] [Related]
38. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
White HD; Assmann SF; Sanborn TA; Jacobs AK; Webb JG; Sleeper LA; Wong CK; Stewart JT; Aylward PE; Wong SC; Hochman JS
Circulation; 2005 Sep; 112(13):1992-2001. PubMed ID: 16186436
[TBL] [Abstract][Full Text] [Related]
39. [Coronary angioplasty for primary cardiogenic shock following acute myocardial infarction].
Badaoui G; Sarkis A; Azar R; Kassab R; Salamé E; Aboujaoudé S
J Med Liban; 2005; 53(4):195-201. PubMed ID: 16836021
[TBL] [Abstract][Full Text] [Related]
40. [Experience with primary coronary angioplasty in management of patients suffering from acute myocardial infarction].
Maslov LN; Krylov AL
Angiol Sosud Khir; 2008; 14(1):131-41. PubMed ID: 19156043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
